Beta-Thalassemia research hub

A Long-term Follow-up Study in Participants Who Received CTX001

This study is looking at the long-term safety and how well a treatment called CTX001 works for children and adults with serious blood conditions like beta-thalassemia and sickle cell disease. It's for people who have already had CTX001 in a previous study.